MetaCap

Pro-Dex (PDEX) vs Utah Medical Products (UTMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Pro-Dex (PDEX) has outperformed Utah Medical Products (UTMD) over the past year, gaining 92.9% versus a gain of 26.0%. Over five years, PDEX leads with a +180.2% price change compared with -42.3% for UTMD. Pro-Dex is the larger company by market cap ($201.6 million vs $198.0 million), about 1.0 times the size.

On valuation, Pro-Dex trades at a lower trailing P/E (17.4x vs 20.8x for Utah Medical Products). Utah Medical Products pays a dividend yielding 1.78%, while Pro-Dex does not currently pay one. Utah Medical Products converts more of its revenue into profit, with a net margin of 29.3% versus 17.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PDEX+92.90%UTMD+25.98%
+131%+62%-7%
Nov 21, 20251 yearNov 20, 2026
PDEX+208.22%UTMD-39.90%
+275%+102%-70%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PDEX versus UTMD key metrics
MetricPDEXUTMD
Share price$63.00$69.49
Market cap$201.60M$198.01M
1-day change-0.77%-2.07%
YTD return+63.72%+24.18%
1-year return+92.90%+25.98%
5-year return+180.25%-42.25%
P/E ratio (TTM)17.3620.81
Forward P/E18.16—
EPS (TTM)$3.63$3.34
Dividend yield0.00%1.78%
Annual dividend$0.00$1.24
Revenue (latest FY)$77.55M$38.52M
Revenue growth (YoY)+16.45%-5.83%
Net income (latest FY)$13.66M$11.29M
Gross margin31.38%57.12%
Operating margin16.75%29.60%
Net margin17.62%29.30%
52-week high$77.00$76.89
52-week low$32.14$53.80
Distance from 52-week high-18.18%-9.62%
Analyst consensusstrong_buy—
Avg. price target upside+26.98%—
Average volume54.15K33.70K
Shares outstanding3.20M2.85M
Employees201140
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • PDEX has outperformed UTMD by 66.9 percentage points over the past year.
  • Utah Medical Products offers a meaningfully higher dividend yield (1.78% vs 0.00%).
  • Utah Medical Products is more profitable, keeping 29.3 cents of every revenue dollar as net income versus 17.6 cents for Pro-Dex.
  • Pro-Dex grew revenue faster in its latest fiscal year (+16.45% vs -5.83%).

About Pro-Dex

PDEX stock →

Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide.

Health Care · Medical/Dental Instruments · 201 employees

About Utah Medical Products

UTMD stock →

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.

Health Care · Medical/Dental Instruments · 140 employees

PDEX vs UTMD FAQ

Which is bigger, Pro-Dex or Utah Medical Products?

Pro-Dex (PDEX) is larger, with a market capitalization of $201.60M compared with $198.01M for Utah Medical Products (UTMD).

Which stock has performed better over the past year, PDEX or UTMD?

PDEX returned +92.90% over the past 12 months, compared with +25.98% for UTMD (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, PDEX or UTMD?

PDEX has the lower trailing P/E at 17.4, versus 20.8 for UTMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Pro-Dex or Utah Medical Products?

Utah Medical Products pays a dividend yielding 1.78%, while Pro-Dex does not currently pay a regular dividend.

Are Pro-Dex and Utah Medical Products in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons